GSDMD and Addictive alcohol use: Disulfiram, a drug approved by the FDA to treat alcohol addiction, has been shown to inhibit GSDMD-mediated inflammasome activation (136). A recent study suggests that pharmacological inhibition of GSDMD by disulfiram reduces the release of NETs from neutrophils and sepsis-mediated multiorgan damage (112).